Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Not applicable Interventional

A 16 Week Evaluation of the Novartis Health Management Tool (HMT) in Age Related Macular Degeneration (AMD)

ClinicalTrials.gov ID: NCT01542866

Public ClinicalTrials.gov record NCT01542866. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 11:34 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 16 Week Evaluation of the Novartis Health Management Tool in Assessing Self-test Visual Function in Patients With AMD Treated With Ranibizumab

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a prospective pilot study to evaluate the usability and applicability of a self monitoring test of visual function with the handheld Health Management Tool (HMT) to remotely monitor neovascular Age Related Macular Degeneration (AMD) to detect a potential change in disease status.

Study identification

NCT ID
NCT01542866
Recruitment status
Completed
Study type
Interventional
Phase
Not applicable
Lead sponsor
Novartis Pharmaceuticals
Industry
Enrollment
160 participants

Conditions and interventions

Eligibility (public fields only)

Age range
Not listed
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 11, 2011 (Actual)
Primary completion
Nov 30, 2011 (Actual)
Completion
Nov 30, 2011 (Actual)
Last update posted
Jul 12, 2018

2011

United States locations

U.S. sites
23
U.S. states
14
U.S. cities
23
Facility City State ZIP Site status
Novartis Investigative Site Beverly Hills California 90211 —
Novartis Investigative Site Sacramento California 95819 —
Novartis Investigative Site Torrance California 90503 —
Novartis Investigative Site Fort Myers Florida 33901 —
Novartis Investigative Site Largo Florida 33770 —
Novartis Investigative Site Sarasota Florida 34239 —
Novartis Investigative Site Springfield Illinois 62704 —
Novartis Investigative Site Williamsburg Michigan 49690 —
Novartis Investigative Site Lincoln Nebraska 68506 —
Novartis Investigative Site Omaha Nebraska 68131 —
Novartis Investigative Site Las Vegas Nevada 89144 —
Novartis Investigative Site Toms River New Jersey 08753 —
Novartis Investigative Site New York New York 10021 —
Novartis Investigative Site Rochester New York 14620 —
Novartis Investigative Site Slingerlands New York 12159 —
Novartis Investigative Site Charlotte North Carolina 28210 —
Novartis Investigative Site Cincinnati Ohio 45242 —
Novartis Investigative Site Cleveland Ohio 44195 —
Novartis Investigative Site West Mifflin Pennsylvania 15122 —
Novartis Investigative Site Rapid City South Dakota 57701 —
Novartis Investigative Site Kingsport Tennessee 37660 —
Novartis Investigative Site Nashville Tennessee 37203 —
Novartis Investigative Site San Antonio Texas 78240 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01542866, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 12, 2018 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01542866 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →